Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

by Mulligan, Mark J., Bernstein, David I., Frey, Sharon, Winokur, Patricia, Rouphael, Nadine, Dickey, Michelle, Edupuganti, Srilatha, Spearman, Paul, Anderson, Edwin, Graham, Irene, Noah, Diana L., Mangal, Brian, Kim, Sonnie, Hill, Heather, Whitaker, Jenifer, Emery, William, Beck, Allison, Stephens, Kathy, Hartwell, Brooke, Ogilvie, Melinda, Rimann, Nayoka, Osinski, Eileen, Destefano, Ellen, Gajadhar, Theda, Strudwick, Amanda, Pierce, Karen, Lai, Lilin, Yue, Ling, Wang, Dongli, Ying, Carl, Cline, Amy, Foltz, Tara, Wagner, Nancy, Dull, Geraldine, Pacatte, Thomas, Taggart, Barbara, Johnson, Valerie, Haller, Logan, Looney, Candi, Li, Shixiong, May, Megan, Myers, Bridgette, May, Rachel, Parker, Lawanda, Cochran, Nertaissa, Bowen, Donna, Bell, Michelle, Scoggins, Jeffery, Burns, Angela, Stablein, Claire, Wolff, Mark, Jolles, Bernadette, Leung, Brenda, Lambert, Linda, Shorer, Shy, Buchanan, Wendy, Murray, Suzanne, Chang, Soju, Gorman, Richard
Published 2014